Journal of Pharmacology and Therapeutic Research is an open access, peer reviewed journal that focuses on the interdisciplinary research offering therapeutic solutions to various neurological, genetics, psychological, and respiratory issues affecting the human beings.

The journal is a quarterly, international, fully peer-reviewed publication.

The editors believe papers published to be original, of sound science, purposeful for risk analysis (valuation, communication, management) and related areas, well written, and a contribution to the scientific works. The journal's emphasis is on publication of papers that contribute to improvements in human health.

The journal constitutes its Editorial-Board comprising scholars from all over the world that offers their critical views on the role of pharmacology in fighting chronic health disorders.

In 2018 the article ‘Recurrent and concurrent subacute stent thrombosis of two coronary arteries in a schizophrenic patient’ was published in our journal which states the subacute stent thrombosis after acute coronary syndrome and concurrent thrombosis of multiple coronary arteries are rare complications. Schizophrenia and antipsychotic drugs cause hypercoagulability, and rates of cardiovascular mortality are higher in schizophrenic patients compared with the normal population. We want to discuss a case of recurrent and concurrent subacute left anterior descending artery and right coronary artery stent thrombosis after acute myocardial infarction in a schizophrenic patient.

It gives us great pleasure to announce the call for paper at special and hefty discount of up to 50 % on one-time article processing charge. Prospective academicians and scientists are encouraged to utilize this opportunity to get their articles reviewed, processed and published at relatively faster pace and at lower charges.

Media contact;

Mark Orwell,

Editorial Manager,

Journal of Pharmacology and Therapeutic Research,

WhatsApp: +19473334405